Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In a phase II trial, people with obesity taking high doses lost up to 24.2 percent of body weight over 48 weeks, eclipsing what is typically seen with single or dual agonists
Generally, given to diabetic patients, it has proven the properties in reducing weight
In females, obesity is often associated with conditions such as polyendocrine metabolic ovarian syndrome (PMOS), formerly knows as PCOS, while in males, it can reduce testosterone levels and adversely affect sperm quality
This includes the physician consultation, the compounded medication, and shipping
US$ 26.90
US$ 22.39
US$ 27.95
US$ 29.52
